In conclusion, we demonstrated that the physical squelching of the AR/ER shared coactivator AIB1 may represent at least one of the several potential mechanisms through which AR can negatively modulate ERα-mediated signalling pathway and inhibit breast cancer cells proliferation. Here, NCOA3 is linked to breast carcinoma.